CXCL13 is a plasma biomarker of germinal center activity

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 10, 2016, Pages 2702-2707

  Havenar Daughton, Colin ^a,b   Lindqvist, Madelene ^b,c   Heit, Antje ^b,d   Wu, Jennifer E ^a   Reiss, Samantha M ^a   Kendric, Kayla ^a   Bélanger, Simon ^a   Kasturi, Sudhir Pai ^e,f   Landais, Elise ^g   Akondy, Rama S ^f   McGuire, Helen M ^h   Bothwell, Marcella ^i,j   Vagefi, Parsia A ^k   Scully, Eileen ^c   Tomaras, Georgia D ^l   Davis, Mark M ^h   Poignard, Pascal ^g,m   Ahmed, Rafi ^b,f   Walker, Bruce D ^b,c,n   Pulendran, Bali ^b,e,f   McElrath, M Juliana ^b,d   Kaufmann, Daniel E ^b,c,o,p   Crotty, Shane ^a,b   more..

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery   (United States)

^c HARVARD UNIVERSITY   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e EMORY UNIVERSITY   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Department of Integrative Structural and Computational Biology   (United States)

^h STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^j RADY CHILDREN'S HOSPITAL   (United States)

^k MASSACHUSETTS GENERAL HOSPITAL   (United States)

^l DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m SCRIPPS RESEARCH INSTITUTE   (United States)

ⁿ HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^o UNIVERSITÉ DE MONTRÉAL   (Canada)

^p CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

more..

Author keywords

Antibodies; CXCL13; HIV; Tfh; Vaccines

Indexed keywords

ANTIVIRUS AGENT; B LYMPHOCYTE RECEPTOR; CHEMOKINE RECEPTOR CXCR5; CXCL13 CHEMOKINE; INFLUENZA VACCINE; NEUTRALIZING ANTIBODY; YELLOW FEVER VACCINE; BIOLOGICAL MARKER;

ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELL MATURATION; COHORT ANALYSIS; CONCENTRATION RESPONSE; CORRELATIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GERMINAL CENTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN TISSUE; IMMUNIZATION; IMMUNOREACTIVITY; INFLUENZA VACCINATION; LONGITUDINAL STUDY; LYMPHOID TISSUE; MACACA; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEPTOR AFFINITY; VIRUS LOAD; ANIMAL; BLOOD; C57BL MOUSE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; LYMPH NODE; VACCINATION;

ANIMALS; BIOMARKERS; CHEMOKINE CXCL13; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GERMINAL CENTER; HIV INFECTIONS; HUMANS; LYMPH NODES; MACACA; MICE, INBRED C57BL; VACCINATION;

EID: 84960933943     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1520112113     Document Type: Article

References (50)

1. Victora GD, Nussenzweig MC (2012) Germinal centers. Annu Rev Immunol 30:429-457.
2. Haynes BF, et al. (2014) Progress in HIV-1 vaccine development. J Allergy Clin Immunol 134(1):3-10.
3. Burton DR, Mascola JR (2015) Antibody responses to envelope glycoproteins in HIV-1 infection. Nat Immunol 16(6):571-576.
4. Sok D, et al. (2013) The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodies. PLoS Pathog 9(11):e1003754.
5. Klein F, et al. (2013) Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization. Cell 153(1):126-138.
6. Burton DR, et al. (2012) A blueprint for HIV vaccine discovery. Cell Host Microbe 12(4): 396-407.
7. Haynes BF (2015) New approaches to HIV vaccine development. Curr Opin Immunol 35:39-47.
8. Crotty S (2014) T follicular helper cell differentiation, function, and roles in disease. Immunity 41(4):529-542.
9. Johnston RJ, et al. (2009) Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 325(5943):1006-1010.
10. Victora GD, et al. (2010) Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter. Cell 143(4):592-605.
11. Gitlin AD, Shulman Z, Nussenzweig MC (2014) Clonal selection in the germinal centre by regulated proliferation and hypermutation. Nature 509(7502):637-640.
12. Ansel KM, et al. (2000) A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406(6793):309-314.
13. Allen CDC, Okada T, Cyster JG (2007) Germinal-center organization and cellular dynamics. Immunity 27(2):190-202.
14. Wang X, et al. (2011) Follicular dendritic cells help establish follicle identity and promote B cell retention in germinal centers. J Exp Med 208(12):2497-2510.
15. Kroenke MA, et al. (2012) Bcl6 and Maf cooperate to instruct human follicular helper CD4 T cell differentiation. J Immunol 188(8):3734-3744.
16. Rasheed A-U, Rahn H-P, Sallusto F, Lipp M, Müller G (2006) Follicular B helper T cell activity is confined to CXCR5(hi)ICOS(hi) CD4 T cells and is independent of CD57 expression. Eur J Immunol 36(7):1892-1903.
17. Widney DP, et al. (2005) Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection. J Interferon Cytokine Res 25(11):702-706.
18. Sansonno D, et al. (2008) Increased serum levels of the chemokine CXCL13 and up-regulation of its gene expression are distinctive features of HCV-related cryoglobulinemia and correlate with active cutaneous vasculitis. Blood 112(5):1620-1627.
19. Lee HT, et al. (2010) Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis. J Rheumatol 37(1):45-52.
20. Wong CK, et al. (2010) Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity. J Clin Immunol 30(1):45-52.
21. Panse J, et al. (2008) Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients. Br J Cancer 99(6):930-938.
22. LocciM, et al. (2013) Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity 39(4):758-769.
23. Landais E, et al. (2016) Broadly neutralizing antibody responses in a large longitudinal sub-Saharan HIV primary infection cohort. PLoS Pathog 12(1):e1005369.
24. Cohen K, Altfeld M, Alter G, Stamatatos L (2014) Early preservation of CXCR5+ PD-1+ helper T cells and B cell activation predict the breadth of neutralizing antibody responses in chronic HIV-1 infection. J Virol 88(22):13310-13321.
25. Hessell AJ, Haigwood NL (2012) Neutralizing antibodies and control of HIV: Moves and countermoves. Curr HIV/AIDS Rep 9(1):64-72.
26. Cohen KW, Dugast A-S, Alter G, McElrath MJ, Stamatatos L (2015) HIV-1 singlestranded RNA induces CXCL13 secretion in human monocytes via TLR7 activation and plasmacytoid dendritic cell-derived type I IFN. J Immunol 194(6):2769-2775.
27. Yu H, Shahsafaei A, Dorfman DM (2009) Germinal-center T-helper-cell markers PD-1 and CXCL13 are both expressed by neoplastic cells in angioimmunoblastic T-cell lymphoma. Am J Clin Pathol 131(1):33-41.
28. Ishikawa S, et al. (2001) Aberrant high expression of B lymphocyte chemokine (BLC/ CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC. J Exp Med 193(12):1393-1402.
29. Sanders RW, et al. (2015) HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers. Science 349(6244):aac4223.
30. Jardine JG, et al. (2015) HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen. Science 349(6244):156-161.
31. Dosenovic P, et al. (2015) Immunization for HIV-1 broadly neutralizing antibodies in human Ig knockin mice. Cell 161(7):1505-1515.
32. Hong JJ, et al. (2014) Early lymphoid responses and germinal center formation correlate with lower viral load set points and better prognosis of simian immunodeficiency virus infection. J Immunol 193(2):797-806.
33. Xu H, Wang X, Lackner AA, Veazey RS (2014) PD-1(HIGH) follicular CD4 T helper cell subsets residing in lymph node germinal centers correlate with B cell maturation and IgG production in rhesus macaques. Front Immunol 5:85.
34. Mylvaganam GH, et al. (2014) Diminished viral control during simian immunodeficiency virus infection is associated with aberrant PD-1hi CD4 T cell enrichment in the lymphoid follicles of the rectal mucosa. J Immunol 193(9):4527-4536.
35. Chowdhury A, et al. (2015) Decreased T follicular regulatory cell/T follicular helper cell (TFH) in simian immunodeficiency virus-infected rhesus macaques may contribute to accumulation of TFH in chronic infection. J Immunol 195(7):3237-3247.
36. Furman D, et al. (2013) Apoptosis and other immune biomarkers predict influenza vaccine responsiveness. Mol Syst Biol 9(1):659.
37. Edupuganti S, et al.; YF-Ig Study Team (2013) A randomized, double-blind, controlled trial of the 17D yellow fever virus vaccine given in combination with immune globulin or placebo: Comparative viremia and immunogenicity. Am J Trop Med Hyg 88(1):172-177.
38. De Rosa SC, et al.; National Institute of Allergy and Infectious Diseases HIV Vaccine Trials Network (2011) HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable. J Immunol 187(6):3391-3401.
39. Bentebibel SE, et al. (2013) Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination. Sci Transl Med 5(176):176ra32.
40. He J, et al. (2013) Circulating precursor CCR7(lo)PD-1(hi) CXCR5+ CD4+ T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. Immunity 39(4):770-781.
41. Finch DK, Ettinger R, Karnell JL, Herbst R, SleemanMA (2013) Effects of CXCL13 inhibition on lymphoid follicles in models of autoimmune disease. Eur J Clin Invest 43(5):501-509.
42. Klimatcheva E, et al. (2015) CXCL13 antibody for the treatment of autoimmune disorders. BMC Immunol 16(1):6.
43. Thompson LJ, Kolumam GA, Thomas S, Murali-Krishna K (2006) Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation. J Immunol 177(3):1746-1754.
44. Johnson MJ, et al. (2012) Type I IFN induced by adenovirus serotypes 28 and 35 has multiple effects on T cell immunogenicity. J Immunol 188(12):6109-6118.
45. Simek MD, et al. (2009) Human immunodeficiency virus type 1 elite neutralizers: Individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm. J Virol 83(14):7337-7348.
46. Lindqvist M, et al. (2012) Expansion of HIV-specific T follicular helper cells in chronic HIV infection. J Clin Invest 122(9):3271-3280.
47. Kasturi SP, et al. (2011) Programming the magnitude and persistence of antibody responses with innate immunity. Nature 470(7335):543-547.
48. Nance JP, Bélanger S, Johnston RJ, Takemori T, Crotty S (2015) Cutting edge: T follicular helper cell differentiation is defective in the absence of Bcl6 BTB repressor domain function. J Immunol 194(12):5599-5603.
49. Lucero CM, et al. (2013) Macaque paneth cells express lymphoid chemokine CXCL13 and other antimicrobial peptides not previously described as expressed in intestinal crypts. Clin Vaccine Immunol 20(8):1320-1328.
50. Choi YS, et al. (2013) Bcl6 expressing follicular helper CD4 T cells are fate committed early and have the capacity to form memory. J Immunol 190(8):4014-4026.